1.Du W*, Wang J, Kuo T, Wang L, McKimpson MW, Son J, Watanabe H, Kitamoto T, Lee Y, Ratner EL, McCune K, Chen Y, Grubbs HB, Thornton EM, Fan J, Sultana N, Diaz B, Balasubramanian I, Gao N, Belvedere S, Accili D*. Pharmacological conversion of gut epithelial cells into insulin-producing cells lowers glycemia in diabetic animals. J Clin Invest. 2022 Oct 25;e162720. doi: 10.1172/JCI162720. Online ahead of print. 2.Lee Y#, Du W#, Nie Y#, Diaz B, Sultana N, Kitamoto T, Leibel R, Accili D, Belvedere S. Single-agent Foxo1 inhibition normalizes glycemia and induces gut β-like cells in streptozotocin-diabetic mice. Mol Metab, 2022 Oct 22;101618. doi: 10.1016/j.molmet.2022.101618. Online ahead of print. (#co-first authors) 3.Fan J#, Du W#, Kim-Muller JY, Son J, Kuo T, Larrea D, Garcia C, Kitamoto T, Kraakman MJ, Owusu-Ansah E, Cirulli V, Accili D. Cyb5r3 links FoxO1-dependent mitochondrial dysfunction with β-cell failure. Mol Metab. 2020 Apr; 34: 97-111. (#co-first authors) |
